Categories AlphaGraphs, Analysis, Finance

Earnings: Citigroup (C) Q2 profit, revenue beat estimates

Citigroup Inc. (NYSE: C) on Friday reported lower earnings and revenues for the second quarter of 2023. The results, however, exceeded analysts’ forecasts.

Citigroup Q2 2023 earnings infographic

The banking behemoth reported a net income of $2.9 billion or $1.33 per share for the June quarter, compared to $4.5 billion or $2.19 per share in the corresponding period of last year. The latest number came in above Wall Street’s projection. Total revenues decreased 1% annually to $19.40 billion but exceeded estimates.

“Amid a challenging macroeconomic backdrop, we continued to see the benefits of our diversified business model and strong balance sheet,” said Citi’s CEO Jane Fraser.

Prior Performance

  • Citigroup Q4 2022 earnings infographic
  • Citigroup Q3 2022 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top